Similar Tracks
Discussing PsA: JAKi Comparative safety & Burden and determinants of multi‑b/tsDMARD failure in PsA
The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Pain reduction & choosing second-line DMARDs after unresponsive first-line DMARDs
The Immune-Mediated Inflammatory Disease Forum
Discussing axSpA: Long-term safety and efficacy of Bimekizumab results from BE-AGILE & BE-MOBILE 1/2
The Immune-Mediated Inflammatory Disease Forum
Webinar Highlights Podcast: IL-17 Inhibition controlling inflammation and disease progression in SpA
The Immune-Mediated Inflammatory Disease Forum
Elon Musk's Family History in South Africa Reveals Ties to Apartheid & Neo-Nazi Movements
Democracy Now!
Forest Cafe Jazz Music | Morning Tranquill Jazz With Nature Therapy For Stress Relief, Study & Wo...
Tranquill Jazz Melody
Scott Galloway on Markets, Musk, and Trump’s “Weapons of Mass Distraction” | Amanpour and Company
Amanpour and Company
Gentle music, calms the nervous system and pleases soul - healing music for heart and blood vessels
Soothing Soul
How sepsis 'silent killer' made Mick O'Dowd a quadruple amputee | Australian Story
ABC News In-depth
Understanding Dementia (Alzheimer's & Vascular & Frontotemporal & Lewy Body Dementia)
Rhesus Medicine
Bimekizumab Shows Favorable Efficacy Compared with Other DMARDs for PsA with Philip J Mease, MD
HCPLive
In Conversation with David Frum: Trump's tariffs against Canada and America's place in the world
The Hub Canada
Webinar: IL-17 Inhibition: Controlling inflammation and disease progression in SpA
The Immune-Mediated Inflammatory Disease Forum
#066 Anti inflammatory food diet for chronic inflammation, chronic pain and arthritis
Dr. Andrea Furlan
Jon Stewart on Trump's Botched Tariff Rollout & The Stock Market's Meltdown | The Daily Show
The Daily Show